Does MEPOLIZUMAB Cause Cholelithiasis? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Cholelithiasis have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.4% of all adverse event reports for MEPOLIZUMAB.
178
Reports of Cholelithiasis with MEPOLIZUMAB
0.4%
of all MEPOLIZUMAB reports
2
Deaths
126
Hospitalizations
How Dangerous Is Cholelithiasis From MEPOLIZUMAB?
Of the 178 reports, 2 (1.1%) resulted in death, 126 (70.8%) required hospitalization.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which MEPOLIZUMAB Alternatives Have Lower Cholelithiasis Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE